Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
03 Gennaio 2017 - 6:09PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 333-196065
Parnell Pharmaceuticals Holdings Ltd
(Exact name of registrant as specified in its charter)
Unit 4, Century Estate. 476 Gardeners Road. Alexandria 2015 NSW, Australia, 1800 665 882
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, no par value
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒
|
|
|
|
Rule 12g-4(a)(2)
|
☐
|
|
|
|
Rule 12h-3(b)(1)(i)
|
☒
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
|
|
Rule 15d-6
|
☐
|
|
|
|
Rule 15d-22(b)
|
☐
|
|
|
Approximate number of holders of record as of the certification or notice date: 37
Pursuant to the requirements of the Securities Exchange Act of 1934, Parnell Pharmaceuticals Holdings Ltd has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
January 3, 2017
By
/s/ Brad McCarthy
Director and Chief Financial Officer
Date Name Title
Grafico Azioni Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Storico
Da Nov 2023 a Nov 2024
Notizie in Tempo Reale relative a Parnell Pharmaceuticals Holdings Ltd (CE) (OTCMarkets): 0 articoli recenti
Più Parnell Pharmaceuticals Holdings Ltd Articoli Notizie